List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 53 studies with search of: "Amprenavir" [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Amprenavir;   Drug: Nevirapine;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
2 Completed An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir
3 Completed A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Amprenavir;   Drug: Lamivudine;   Drug: Zidovudine
4 Completed A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Nelfinavir mesylate;   Drug: Lamivudine
5 Completed A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Nelfinavir mesylate;   Drug: Efavirenz;   Drug: Levocarnitine;   Drug: Adefovir dipivoxil;   Drug: Saquinavir
6 Completed A Study of Amprenavir in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Amprenavir
7 Active, not recruiting Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Lamivudine;   Drug: Zidovudine
8 Completed A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Lamivudine
9 Completed Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Amprenavir;   Drug: Nelfinavir mesylate;   Drug: Efavirenz;   Drug: Saquinavir
10 Completed A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz
11 Completed A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications
Condition: HIV Infections
Intervention: Drug: Amprenavir
12 Completed Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Drug: Adefovir dipivoxil
13 Completed A Comparison of 141W94 and Indinavir in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Amprenavir
14 Completed Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
Condition: HIV Infection
Interventions: Drug: Abacavir;   Drug: Amprenavir;   Drug: Efavirenz
15 Completed Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.
Condition: HIV Infections
Interventions: Drug: Amprenavir (drug);   Drug: ABT-378/r (drug);   Drug: Ritonavir (drug)
16 Completed The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz
17 Completed Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors
Condition: HIV Infections
Intervention: Drug: Amprenavir
18 Active, not recruiting Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Stavudine
19 Active, not recruiting Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Amprenavir
20 Completed A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Amprenavir;   Drug: Lamivudine;   Drug: Zidovudine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services